Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC) Share Price

Price 88.60p on 03-04-2026 at 04:45:16
Change 0.00p 0%
Buy 89.90p
Sell 88.20p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 25,000.00 at 88.3063p
Day's Volume: 0
Last Close: 88.60p
Open: 0.00p
ISIN: GG00B8P59C08
Day's Range 0.00p - 0.00p
52wk Range: 79.10p - 102.60p
Market Capitalisation: £538.86m
VWAP: 0.00p
Shares in Issue: 608.19m

Sector: Closed End Investments

Listed In: FTSE All-Share, FTSE Lower Yield, FTSE 250, FTSE 350

Syncona (SYNC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 25,000 88.3063p Ordinary
 16:29:29 - 02-Apr-26
Sell* 1,818 88.30p Automatic Execution
 16:29:19 - 02-Apr-26
Sell* 4,005 88.30p Automatic Execution
 16:29:19 - 02-Apr-26
Sell* 25,000 88.40p Ordinary
 16:29:12 - 02-Apr-26
Buy* 70 89.80p Automatic Execution
 16:28:07 - 02-Apr-26
Buy* 1,751 89.80p Automatic Execution
 16:28:07 - 02-Apr-26
Buy* 170 89.80p Automatic Execution
 16:28:07 - 02-Apr-26
Sell* 25,000 89.3251p Ordinary
 16:27:55 - 02-Apr-26
Sell* 450 89.30p Automatic Execution
 16:20:00 - 02-Apr-26
Sell* 38,496 89.00p Negotiated Trade
 16:08:08 - 02-Apr-26
See more Syncona trades

Syncona (SYNC) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Apr 2026 (Thu) 88.20 89.80 88.20 88.60 813,564
1st Apr 2026 (Wed) 91.20 91.20 88.10 88.10 464,897
31st Mar 2026 (Tue) 91.10 93.00 88.50 88.50 361,592
30th Mar 2026 (Mon) 91.10 92.70 91.10 91.20 970,072
27th Mar 2026 (Fri) 92.20 92.40 92.00 92.00 509,828
26th Mar 2026 (Thu) 91.70 92.10 91.70 91.80 269,440
25th Mar 2026 (Wed) 91.40 93.80 91.40 93.00 277,304
24th Mar 2026 (Tue) 93.90 93.90 91.30 91.50 485,262
23rd Mar 2026 (Mon) 93.00 93.00 91.30 91.40 498,433
20th Mar 2026 (Fri) 95.90 95.90 93.20 93.20 1,413,420
19th Mar 2026 (Thu) 96.30 96.30 93.00 93.70 533,990
18th Mar 2026 (Wed) 96.80 96.80 94.70 95.40 405,855
17th Mar 2026 (Tue) 96.40 96.60 94.10 94.30 870,831
16th Mar 2026 (Mon) 94.30 95.20 94.10 94.10 216,779
13th Mar 2026 (Fri) 96.80 96.80 94.60 94.60 342,660
12th Mar 2026 (Thu) 96.40 96.40 94.10 95.00 400,021
11th Mar 2026 (Wed) 94.60 96.00 94.00 96.00 652,691
10th Mar 2026 (Tue) 94.00 96.90 94.00 94.80 381,343
9th Mar 2026 (Mon) 97.00 97.00 93.80 93.80 496,916
6th Mar 2026 (Fri) 95.60 96.00 95.60 95.60 587,733
5th Mar 2026 (Thu) 96.90 96.90 95.60 95.60 1,063,311
4th Mar 2026 (Wed) 96.10 96.90 95.60 96.10 419,135
3rd Mar 2026 (Tue) 95.00 97.00 95.00 97.00 265,359
See more Syncona price history

Syncona (SYNC) Regulatory News

Date Source Headline
16th Mar 2026 2:16 pm RNS Holding(s) in Company
16th Mar 2026 2:16 pm RNS Holding(s) in Company
3rd Mar 2026 11:00 am RNS Results of General Meeting and Board Changes
3rd Mar 2026 9:30 am RNS Quell Clinical Updates
12th Feb 2026 12:00 pm RNS Publication of Circular
5th Feb 2026 7:00 am RNS Third Quarter Update
8th Jan 2026 12:01 pm RNS Beacon raises $75m in oversubscribed Series C
28th Nov 2025 6:00 pm RNS Total Voting Rights
17th Nov 2025 7:00 am RNS Issue of shares pursuant to incentive scheme
13th Nov 2025 7:00 am RNS Half-year Report
See more Syncona regulatory news

Syncona (SYNC) Share News

IN BRIEF: Syncona invests GBP18 million in Beacon financing round

8th Jan 2026 15:45

Syncona Ltd - London-based investor in life science companies - Invests USD24.5 million in ophthalmic gene therapy company Beacon Therapeutics' USD75 million Series C financing. Says the financing round was oversubscribed and brings Beacon's total funding raised so far to approximately USD367 million. Beacon will use the proceeds "to progress commercialisation plans" and to complete the development of its lead programme laru-zova, "a potential best-in-class gene therapy" for X-linked retinitis pigmentosa, Syncona says. Syncona's holding value of Beacon will now be USD237.6 million, including new capital invested, and it will hold a 38.4% ownership stake. Read More

Syncona says positioned for biotech growth after net asset value fall

13th Nov 2025 13:02

(Alliance News) - Syncona Ltd on Thursday reported a fall in its net asset value but said it is well-positioned to deliver value as market conditions in biotech improve. Read More

TRADING UPDATES: eEnergy expands agreement; ACG Metals fundraise

12th Nov 2025 21:21

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Syncona to focus on realisations to return GBP250 million

21st Oct 2025 13:25

Syncona Ltd - London-based investor in life science companies - Sets out results of its strategy review, proposing focus on realisations of mature private companies in its portfolio until it has been able to return up to GBP250 million to shareholders "in a timely manner". The returns, representing about 40% of the company's current market value, could take the form of a tender offer, share buyback, or special dividend, Syncona says. Read More

CORRECT: FTSE rises as UK borrowing hits five-year high

21st Oct 2025 09:21

(Clarifying that Brent oil was trading higher early Tuesday, not lower.) Read More

See more Syncona news
FTSE 100 Latest
Value10,436.29
Change71.50

Login to your account

Forgot Password?

Not Registered